Document is current

Any future updates will be listed below

Quercetin and doxorubicin co-delivery using β-cyclodextrin nanocarrier overcomes multi-drug resistance in cancer cells via targeting Akt/NF-κB/ABCB1 signaling pathway

Crossref DOI link: https://doi.org/10.1007/s42247-024-00845-4

Published Online: 2024-09-04

Published Print: 2025-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark